Application 1100
Intersphinteric Injection of Silicone Biomaterial for Severe Passive Faecal Incontinence
Intersphinteric Injection of Silicone Biomaterial for Severe Passive Faecal Incontinence
Application No. | 1100 |
| Application Name | Intersphinteric Injection of Silicone Biomaterial for Severe Passive Faecal Incontinence |
| Advisory Panels | Dr Doug Travis (Chair and MSAC member) Dr Nicholas Rieger (Royal Australian College of Surgeons nominee) Dr Ewa Peijko (MSAC member) Dr James Keck (Colorectal Surgery Soicety of Australia nominee) Dr Michael Whishaw (co-opted member) Ms Sheila Rimmer (Consumers' Health Forum of Australia nominee) |
| Date Received by MSAC Secretariat | August 2005 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 15 November 2006 meeting. Intersphincteric injection of silicone biomaterial for severe passive faecal incontinence appears to be safe. There is some low level evidence of short-term effectiveness but no evidence of long-term effectiveness. In view of the lack of acceptable alternative therapies, a limited assessment of the financial impact was carried out. This demonstrated high cost mainly due to the cost of the prosthesis. MSAC does not recommend public funding for this procedure at this time. |
| Stage 4 - Decision | Endorsed by the Minister for Health and Ageing on 5 February 2007 |
| Stage 5 - Implementation |  |
